CF Benchmarks, the leading provider of cryptocurrency benchmark indices announces the launch of 11 new cryptocurrency reference rates and real-time indices to the CME CF Cryptocurency Pricing Products, which will be calculated and published daily beginning April 25 and give benchmark index pricing for the below assets:
“Extending the CME CF Cryptocurrency Reference Rates and Real Time Indices further underlines the commitment of both CF Benchmarks and CME Group to serving investors of all types with robust benchmark pricing across a wider range of cryptocurrency assets, said Sui Chung, CEO of CF Benchmarks. “This also further adds to the continued adoption of the digital asset class through regulated investment products and funds.”
“Enhancing market infrastructure means a broader range of investors can easily engage in the digital asset class,” said Juthica Chou, Head of OTC Options Trading at Kraken. “The launch of 11 new indices opens the door for traditional investors to gain exposure to a much broader range of cryptocurrencies through a suite of products they are already familiar with.”
“Evolve’s physical-crypto ETFs rely on CME CF Reference Rates to provide liquidity, tight tracking and reliable NAV for investors,” says Elliot Johnson, Chief Investment Officer at Evolve ETFs. “We’re very excited to see the CME CF index family expanding to lay the foundation for new, innovative ETFs in this highly coveted asset class.”
“The transparency and robustness of the new CME CF Reference Rates enable a much broader range of products representing the diversity of crypto assets,” said Joshua Lim, Head of Derivatives at Genesis Global Trading. “We’re excited to be a liquidity partner on the variety of instruments that will be built on top of them.” Each of these new reference rates will provide the U.S. dollar price of each digital asset, published once-a-day at 4 p.m. London time, while each respective real-time index will be published once per second, 24 hours a day, 365 days per year.
For licensing opportunities please contact [email protected]
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.